This is a synthetic peptide designed for use in combination with anti-GABARAPL1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
GABARAPL1
Reaktivität: Human
Wirt: Synthetic
BP, WB, IHC
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
GABARAPL1
(GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1))
Synonyme
gabarapl1 Peptide, apg8l Peptide, atg8 Peptide, atg8l Peptide, gec1 Peptide, gabarapl1-a Peptide, GABARAPL3 Peptide, APG8-LIKE Peptide, APG8L Peptide, ATG8 Peptide, ATG8B Peptide, ATG8L Peptide, GEC1 Peptide, Gec1 Peptide, 3110025G09Rik Peptide, 9130422N19Rik Peptide, AI196471 Peptide, Apg8l Peptide, Atg8l Peptide, GECI Peptide, GEC-1 Peptide, GABA(A) receptor-associated protein like 1 Peptide, GABA(A) receptor-associated protein like 1 S homeolog Peptide, GABA type A receptor associated protein like 1 Peptide, gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 Peptide, gabarapl1 Peptide, gabarapl1.S Peptide, GABARAPL1 Peptide, Gabarapl1 Peptide
Hintergrund
GABARAPL1 is a Ubiquitin-like modifier that increases cell-surface expression of kappa-type opioid receptor through facilitating anterograde intracellular trafficking of the receptor. it is involved in formation of autophagosomal vacuoles. Whereas LC3s are involved in elongation of the phagophore membrane, the GABARAP/GATE-16 subfamily is essential for a later stage in autophagosome maturation.